|
|
|
(Adjusted for age and population. Last graph update 02/17/23). Click to enlarge.
After three years of pandemic, the best age-adjusted data indicates that residents of the U.S. & the West are about 15 times more likely to die of coronavirus infection than those in sub-Saharan Africa. Click here to see what's new in 2022, or 2023?
Is anyone looking at these unexpected, disparate African outcomes?
The best data indicates that antimalarial agents Malarone (atovaquone/proguanil) and artemisinin
have greater crossover efficacy against COVID than hydroxychloroquine or ivermectin.
We are told to follow the science! Whose science?
We must follow the data! Click here to see what's new in 2022, or 2023.
Wholly apart from this African data, the U.S. Government experts (NIH, CDC, FDA & HHS) who dismiss sub-Saharan Africa's superior COVID outcomes have, themselves, COVID outcomes (death rates) which are more than 200% (three times) worse than the entire rest of the world.
This graphic depiction of this truth is easily produced on the "Our World in Data" website. The data itself is also readily available, e.g. on the Johns Hopkins COVID-19 Dashboard website. With this level of clinical performance over the past year, can U.S. medical experts be trusted in their dismissive assessment of African outcomes and practices?
Click to enlarge.
last update 02/17/23
Is anyone looking at these unexpected, disparate African outcomes?
The best data indicates that antimalarial agents Malarone (atovaquone/proguanil) and artemisinin
have greater crossover efficacy against COVID than hydroxychloroquine or ivermectin.
We are told to follow the science! Whose science?
We must follow the data! Click here to see what's new in 2022, or 2023.
|
Wholly apart from this African data, the U.S. Government experts (NIH, CDC, FDA & HHS) who dismiss sub-Saharan Africa's superior COVID outcomes have, themselves, COVID outcomes (death rates) which are more than 200% (three times) worse than the entire rest of the world. |
last update 02/17/23 |